Biologically meaningful information about heterogeneous cell populations must include insights into their spatial organization within their native tissue niche. However, traditional techniques such as immunohistochemistry or flow cytometry are limited by their inability to provide both spatial context and high-throughput cellular phenotyping simultaneously. ChipCytometry™ Spatial Multiplexing Technology addresses these limitations by combining multiplex immunofluorescence with high-dynamic range spatial imaging to produce superior single-cell resolution of morphologically intact tissue samples.
In this webinar brought to you by Canopy Biosciences, J. Spencer Schwarz will explore how spatial multiplexing revolutionizes scientists’ understanding of spatially heterogenous cell populations in normal and diseased tissues through comprehensive, spatially relevant cellular phenotyping.
Topics to be covered
Technical challenges of generating biologically relevant spatial biology data
Considerations for employing high-multiplex assays in clinical studies
Benefits and considerations for employing multiplexing methods that require a range of abstractions compared to traditional methods
Thursday, March 17, 2022
11:00 AM - 12:00 PM Eastern Time
This webinar will also be available on-demand.
Meet the speaker
J. Spencer Schwarz, MS Product Manager, ChipCytometry™ Instrumentation Canopy Biosciences® – A Bruker Company
Sponsored by
Register
TS_Webinar_Bio-Rad_LabTools_Droplet Digital PCR: When qPCR Doesn’t Make the Cut November 4, 2021_IO#403220
You must have Javascript and Cookies enabled to access this webcast.
Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
.bmp "thermo"){kind=logo}
